These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16503385)

  • 1. Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys.
    Jaggi JS; Seshan SV; McDevitt MR; Sgouros G; Hyjek E; Scheinberg DA
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1503-12. PubMed ID: 16503385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal tubulointerstitial changes after internal irradiation with alpha-particle-emitting actinium daughters.
    Jaggi JS; Seshan SV; McDevitt MR; LaPerle K; Sgouros G; Scheinberg DA
    J Am Soc Nephrol; 2005 Sep; 16(9):2677-89. PubMed ID: 15987754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor antagonists in the prevention of radiation nephropathy.
    Moulder JE; Fish BL; Cohen EP; Bonsib SM
    Radiat Res; 1996 Jul; 146(1):106-10. PubMed ID: 8677292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker.
    Chrysostomou A; Pedagogos E; MacGregor L; Becker GJ
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):256-62. PubMed ID: 17699214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathy.
    Moulder JE; Fish BL; Cohen EP
    Int J Radiat Biol; 1998 Apr; 73(4):415-21. PubMed ID: 9587080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation nephropathy in rats and its modification by the angiotensin converting enzyme inhibitor enalapril.
    Yildiz F; Atahan II; Yildiz O
    Radiat Med; 2000; 18(3):153-9. PubMed ID: 10972545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efforts to control the errant products of a targeted in vivo generator.
    Jaggi JS; Kappel BJ; McDevitt MR; Sgouros G; Flombaum CD; Cabassa C; Scheinberg DA
    Cancer Res; 2005 Jun; 65(11):4888-95. PubMed ID: 15930310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
    Liu D; Nazneen A; Taguchi T; Razzaque MS
    Am J Nephrol; 2008; 28(4):555-68. PubMed ID: 18239382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril preserves function and ultrastructure in experimental radiation nephropathy.
    Cohen EP; Molteni A; Hill P; Fish BL; Ward WF; Moulder JE; Carone FA
    Lab Invest; 1996 Sep; 75(3):349-60. PubMed ID: 8804358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates.
    Miederer M; McDevitt MR; Sgouros G; Kramer K; Cheung NK; Scheinberg DA
    J Nucl Med; 2004 Jan; 45(1):129-37. PubMed ID: 14734685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type-1 (AT1) receptor antagonist.
    Moulder JE; Fish BL; Cohen EP
    Radiother Oncol; 1998 Mar; 46(3):307-15. PubMed ID: 9572624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief pharmacological intervention in experimental radiation nephropathy.
    Moulder JE; Fish BL; Cohen EP
    Radiat Res; 1998 Nov; 150(5):535-41. PubMed ID: 9806595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epoxyeicosatrienoic acid analogue mitigates kidney injury in a rat model of radiation nephropathy.
    Hye Khan MA; Fish B; Wahl G; Sharma A; Falck JR; Paudyal MP; Moulder JE; Imig JD; Cohen EP
    Clin Sci (Lond); 2016 Apr; 130(8):587-99. PubMed ID: 26772189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.
    van den Meiracker AH; Baggen RG; Pauli S; Lindemans A; Vulto AG; Poldermans D; Boomsma F
    J Hypertens; 2006 Nov; 24(11):2285-92. PubMed ID: 17053552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of connective tissue growth factor in experimental radiation nephropathy in rats.
    Liu DG; Wang TM
    Chin Med J (Engl); 2008 Oct; 121(19):1925-31. PubMed ID: 19080126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibitor captopril does not prevent acute gastrointestinal radiation damage in the rat.
    Moulder JE; Fish BL
    Radiat Oncol Investig; 1997; 5(2):50-3. PubMed ID: 9303057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide ameliorates inflammation and vascular injury but aggravates tubular damage in the irradiated mouse kidney.
    Scharpfenecker M; Floot B; Russell NS; Coppes RP; Stewart FA
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):599-606. PubMed ID: 24929166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful brief captopril treatment in experimental radiation nephropathy.
    Cohen EP; Fish BL; Moulder JE
    J Lab Clin Med; 1997 May; 129(5):536-47. PubMed ID: 9142050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of radiation nephropathy with captopril.
    Cohen EP; Fish BL; Moulder JE
    Radiat Res; 1992 Dec; 132(3):346-50. PubMed ID: 1475357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.